◼ Archived
Business
Updated: Electra says $350M IPO will help it become a commercial biotech
Immunology drugmaker Electra Therapeutics pursues an upsized $350 million initial public offering on Nasdaq under the ticker ETRA.
4 trends tracked about this subject — the full history, oldest to newest below.
Immunology drugmaker Electra Therapeutics pursues an upsized $350 million initial public offering on Nasdaq under the ticker ETRA.
5 news sources are covering this Entertainment story right now — PULSE is tracking how fast it spreads.
6 news sources are covering this Entertainment story right now — PULSE is tracking how fast it spreads.
Electra is investing up to $1 billion to establish a manufacturing plant in Springfield, Ohio, for its EL9 hybrid-electric aircraft.